HeimAMBBY • OTCMKTS
add
Ambu
Við síðustu lokun
13,60 $
Dagbil
13,20 $ - 13,20 $
Árabil
12,56 $ - 20,24 $
Markaðsvirði
20,68 ma. DKK
Meðalmagn
61,00
V/H-hlutf.
-
A/V-hlutfall
-
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (DKK) | sep. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 1,47 ma. | 5,70% |
Rekstrarkostnaður | 732,00 m. | 9,25% |
Nettótekjur | 115,00 m. | 185,19% |
Hagnaðarhlutfall | 7,84 | 180,58% |
Hagnaður á hvern hlut | 0,43 | -0,26% |
EBITDA | 183,00 m. | -24,38% |
Virkt skatthlutfall | 23,33% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (DKK) | sep. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 866,00 m. | 40,81% |
Heildareignir | 7,68 ma. | 7,28% |
Heildarskuldir | 1,64 ma. | 5,13% |
Eigið fé alls | 6,04 ma. | — |
Útistandandi hlutabréf | 266,56 m. | — |
Eiginfjárgengi | 0,60 | — |
Arðsemi eigna | 4,88% | — |
Ávöxtun eigin fjár | 5,64% | — |
Peningaflæði
Breyting á handbæru fé
| (DKK) | sep. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 115,00 m. | 185,19% |
Handbært fé frá rekstri | 249,00 m. | 29,02% |
Reiðufé frá fjárfestingum | -119,00 m. | -25,26% |
Reiðufé frá fjármögnun | -15,00 m. | 16,67% |
Breyting á handbæru fé | 115,00 m. | 41,98% |
Frjálst peningaflæði | 121,88 m. | 20,82% |
Um
Ambu, or officially Ambu A/S, is a Danish company that develops, produces and markets single-use endoscopy solutions, diagnostic and life-supporting equipment to hospitals, private practices, and rescue services.
It was founded in Denmark in 1937, as Testa Laboratorium, by German engineer Holger Hesse.
The largest business areas are anesthesia, cardiology, neurology, pulmonology, urology and gastroenterology. The company's most important products are devices for artificial ventilation, single-use endoscopes and single-use electrodes for ECG tests and neurophysiological mappings. Wikipedia
Framkvæmdastjóri
Stofnsett
1937
Vefsvæði
Starfsfólk
5.384
